E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 10/31/2020 in the Prospect News Structured Products Daily.

New Issue: HSBC sells $486,000 callable contingent income barrier notes on ETFs

By Taylor Fox

New York, Nov. 2 – HSBC USA Inc. priced $486,000 of callable contingent income barrier notes due Oct. 6, 2023 linked to the least performing of the SPDR S&P Biotech ETF and the Technology Select Sector SPDR fund, according to a 424B2 filing with the Securities and Exchange Commission.

Semiannually, the notes will pay a contingent coupon at an annual rate of 9.5% if each ETF closes at or above its coupon trigger level, 60% of its initial level, on the observation date for that period.

The notes can be called at par plus the contingent coupon on any semiannual call payment date.

The payout at maturity will be par plus the final coupon if each ETF finishes at or above its 60% barrier level. Otherwise, investors will be fully exposed to the decline of the lowest performing ETF.

HSBC Securities (USA) Inc. is the agent.

Issuer:HSBC USA Inc.
Issue:Callable contingent income barrier notes
Underlying ETFs:SPDR S&P Biotech ETF and the Technology Select Sector SPDR fund
Amount:$486,000
Maturity:Oct. 6, 2023
Coupon:9.5% per year, payable semiannually if each ETF closes at or above coupon trigger level on determination date for that period
Price:Par
Payout at maturity:If each ETF finishes at or above barrier level, par plus coupon; otherwise, full exposure to losses of worst performer
Call option:At par plus the contingent coupon on any semiannual call payment date
Initial levels:$112.83 for Biotech and $117.93 for SPDR
Coupon/barrier levels:60% of initial levels
Pricing date:Oct. 1
Settlement date:Oct. 6
Agent:HSBC Securities (USA) Inc.
Fees:None
Cusip:40438CXE6

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.